Clinical Trial Update: 1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

This document updates on a phase 2 clinical trial evaluating galeterone in combination with gemcitabine for metastatic pancreatic adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Galeterone (galeterone)
• Gemzar (gemcitabine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING